Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1 Agnosia 1

Interventions

Fulvestrant 85 Letrozole 79 Paclitaxel 76 pembrolizumab 72 Specimen Handling 65 Trastuzumab 62 Carboplatin 56 Magnetic Resonance Spectroscopy 52 ribociclib 49 Capecitabine 49 Anastrozole 48 pertuzumab 46 palbociclib 45 exemestane 40 Tamoxifen 40 Cyclophosphamide 40 abemaciclib 39 Biopsy 38 trastuzumab deruxtecan 31 Docetaxel 30 Taxes 27 Radiotherapy 27 Gemcitabine 25 Blood Specimen Collection 25 130-nm albumin-bound paclitaxel 24 Surveys and Questionnaires 23 Standard of Care 22 olaparib 21 sacituzumab govitecan 20 eribulin 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Botulinum Toxins, Type A × Breast × 90 days × Clear all

NCT06807164 2026-03-27

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting

Agnosia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡